Physicochemical Properties
| Molecular Formula | C5H4N2O |
| Molecular Weight | 108.10 |
| Exact Mass | 108.032 |
| CAS # | 79917-37-6 |
| PubChem CID | 149263 |
| Appearance | Light brown to yellow solid powder |
| LogP | 1.479 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Heavy Atom Count | 8 |
| Complexity | 84.5 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C1=CC=NC(=C1)N=O |
| InChi Key | UJMHYOGYJDQSOH-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C5H4N2O/c8-7-5-3-1-2-4-6-5/h1-4H |
| Chemical Name | 2-nitrosopyridine |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Timothy A. Wencewicz, et al. N-O Chemistry for Antibiotics: Discovery of N-Alkyl-N-(pyridin-2-yl) hydroxylamine Scaffolds as Selective Antibacterial Agents Using Nitroso Diels?Alder and Ene Chemistry. Journal of Medicinal Chemistry, 54(19), 6843–6858. [2]. Debin Wan, et al. A new sensitive LC/MS/MS analysis of vitamin D metabolites using a click derivatization reagent, 2-nitrosopyridine. J Lipid Res. 2017 Apr; 58(4): 798–808. |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (925.07 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (23.13 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (23.13 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 9.2507 mL | 46.2535 mL | 92.5069 mL | |
| 5 mM | 1.8501 mL | 9.2507 mL | 18.5014 mL | |
| 10 mM | 0.9251 mL | 4.6253 mL | 9.2507 mL |